| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 158,791 | 157,715 | 162,573 | 221,460 | | Cost of Revenue | 97,528 | 100,642 | 103,502 | 134,613 | | | Gross Profit | 61,263 | 57,073 | 59,071 | 86,847 | | | Operating Expenses | | Research Development | 14,065 | 15,375 | 15,913 | 15,867 | | Selling General and Administrative | 44,459 | 44,710 | 51,009 | 60,935 | | Non Recurring | 2,704 | 7,345 | 8,582 | 2,411 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 35 | (10,357) | (16,433) | 7,634 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 325 | 261 | 341 | 1,067 | | Earnings Before Interest And Taxes | 360 | (10,096) | (16,092) | 8,701 | | Interest Expense | 261 | 226 | 226 | 229 | | Income Before Tax | 99 | (10,322) | (16,318) | 8,472 | | Income Tax Expense | 35 | (3,781) | (5,917) | (808) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 64 | (6,541) | (10,401) | 9,280 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 64 | (6,541) | (10,401) | 9,280 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $64 | ($6,541) | ($10,401) | $9,280 |
|
0.31% Nasdaq 0.00%
Income Statement
